The Authority shall monitor a clinical trial from the beginning to the end in order to ensure adequate protection of the general public against the risks or adverse events from the authorized clinical trial to satisfy itself that the specific and general conditions subject to which the trial was authorized are being strictly adhered to by the person conducting the trial and that the trial will achieve its aims and objectives.